Henry Schein 2013 Annual Report Download - page 24

Download and view the complete annual report

Please find page 24 of the 2013 Henry Schein annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

15
Proprietary Rights
We hold trademarks relating to the “Henry Schein” name and logo, as well as certain other trademarks.
Pursuant to agreements executed in connection with our reorganization in 1994, both Henry Schein, Inc. and Schein
Pharmaceutical, Inc. (which was acquired by Watson Pharmaceuticals, Inc. in 2000), a company previously
engaged in the manufacture and distribution of multi-source pharmaceutical products, are entitled to use the
“Schein” name in connection with their respective businesses, but Schein Pharmaceutical, Inc. must always use
“Schein” in combination with the word “Pharmaceutical” and is not entitled to use the name “Henry Schein” or to
use “Schein” alone or with any other word (other than “Pharmaceutical”). We intend to protect our trademarks to
the fullest extent practicable.
Employees
As of December 28, 2013, we employed more than 16,000 full-time employees, including approximately 1,700
telesales representatives, 3,400 field sales consultants, including equipment sales specialists, 3,100 warehouse
employees, 750 computer programmers and technicians, 1,525 management employees and 5,725 office, clerical
and administrative employees. Over 320 or 2.0% of our employees were subject to collective bargaining
agreements. We believe that our relations with our employees are excellent.
Available Information
We make available free of charge through our Internet website, www.henryschein.com, our annual report on
Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, statements of beneficial ownership of
securities on Forms 3, 4 and 5 and amendments to these reports and statements filed or furnished pursuant to
Section 13(a) and Section 16 of the Securities Exchange Act of 1934 as soon as reasonably practicable after such
materials are electronically filed with, or furnished to, the United States Securities and Exchange Commission, or
SEC.
The above information is also available at the SEC’ s Office of Investor Education and Advocacy at United
States Securities and Exchange Commission, 100 F Street, N.E., Washington, D.C. 20549-0213 or obtainable by
calling the SEC at (800) 732-0330. In addition, the SEC maintains an Internet website at www.sec.gov, where the
above information can be viewed.
Our principal executive offices are located at 135 Duryea Road, Melville, New York 11747, and our telephone
number is (631) 843-5500. Unless the context specifically requires otherwise, the terms the “Company,” “Henry
Schein,” “we,” “us” and “our” mean Henry Schein, Inc., a Delaware corporation, and its consolidated subsidiaries.